ONVO 1 (-2.91%)
US68620A2033Medical Diagnostics & ResearchDiagnostics & Research

Organovo Holdings (ONVO) Competitor Comparison

We are evaluating the key criteria listed to compare Organovo Holdings (ONVO) against its competitors in the Diagnostics & Research industry.

Performance 10 years - ONVO ranking 56 / 58

These are the competitors of Organovo Holdings in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. DexCom DXCM
1.32K
3. Medpace Holdings MEDP
1.22K
4. Lantheus Holdings LNTH
942.65
5. RadNet RDNT
938.39
6. IDEXX Laboratories IDXX
705.33
7. Icon ICLR
559.57
8. Mettler-Toledo MTD
408.64
9. Natera NTRA
373.78
10. Exact Sciences EXAS
371.46
11. Thermo Fisher Scientific TMO
357.11
12. IQVIA Holdings IQV
352.83
13. NeoGenomics NEO
329.52
14. Danaher DHR
323.44
15. Charles River Laboratories CRL
297.02
16. PerkinElmer PKI
247.07
17. Agilent Technologies A
239.79
18. Waters WAT
166.18
19. Laboratory Corp of America Holdings LH
131.91
20. Fulgent Genetics FLGT
121.06
21. Quest Diagnostics DGX
116.37
22. Twist Bioscience TWST
115
23. Syneos Health SYNH
113.83
24. National Research NRC
110.58
25. Qiagen QGEN
86.07
26. Meridian Bioscience VIVO
60.69
27. SeqLL SQL
59.42
28. Inotiv NOTV
52.11
29. Ortho Clinical Diagnostics Holdings OCDX
13.74
30. CareDx CDNA
-12.53
31. Illumina ILMN
-13.54
32. Neogen NEOG
-27.02
33. Sera Prognostics SERA
-35.04
34. Olink Holding OLK
-38.64
35. Guardant Health GH
-42.09
36. Myriad Genetics MYGN
-51.75
37. Anixa Biosciences ANIX
-52
38. Sotera Health SHC
-59.44
39. Pacific Biosciences of California PACB
-65.93
40. Global Cord Blood CO
-66.57
41. bioAffinity Technologies BIAF
-66.9
42. DarioHealth DRIO
-69.07
43. Bioventus BVS
-70.33
44. Enzo Biochem ENZ
-74.88
45. MaxCyte MXCT
-76.75
46. Co-Diagnostics CODX
-80.83
47. MDxHealth MDXH
-81.65
48. Psychemedics PMD
-84.68
49. Neuronetics STIM
-84.8
50. Biodesix BDSX
-90.8
51. Aspira Womens Health AWH
-91.66
52. Exagen XGN
-91.85
53. Trinity Biotech TRIB
-92.15
54. Personalis PSNL
-94.53
55. Prenetics Global PRE
-97.58
56. Organovo Holdings ONVO
-99.2
57. Interpace Biosciences IDXG
-99.72
58. Precipio PRPO
-99.76

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.